Biotech 2050 Podcast

Inside the Journey of Abcuro: CEO Alex Martin on Leadership, IBM, and the Future of Biotech


Listen Later

Synopsis:
In this episode of Biotech 2050, Alex Martin, CEO of Abcuro, sits down with host Rahul Chaturvedi to share his inspiring journey from aspiring actor to biotech trailblazer. Alex reveals how his unique background shaped his leadership approach as he drives Abcuro’s groundbreaking work on Inclusion Body Myositis (IBM), a rare muscle disease with no current treatments. He offers valuable insights for biotech CEOs on navigating the complexities of fundraising, building mission-driven teams, and fostering productive relationships with boards. Tune in to discover how Alex is leading Abcuro to the forefront of biotech innovation and making a profound impact on patient lives.
Biography:
Alex Martin brings over 30 years of experience building companies and closing transactions in the biopharmaceutical industry. He was most recently Chief Executive Officer of Palladio Biosciences, a clinical stage biopharmaceutical company which was acquired by Centessa Pharmaceuticals (CNTA), and previously served as Chief Executive Officer of Realm Therapeutics (RLM) which was acquired by ESSA Pharma (EPIX). He was also Chief Operating Officer of Intercept Pharmaceuticals (ICPT), and Chief Finance Officer of BioXell (BXLN) which was acquired by Cosmo Pharmaceuticals (COPN). He began his career at SmithKline Beecham Pharmaceuticals where he held roles of increasing responsibility in marketing and business development and later joined Novartis as Vice President, Global Business Development & Licensing. Alex is an active coach and mentor to other senior executives, and a guest lecturer at Wharton and Columbia Business School on biotech, entrepreneurship, and raising capital. He holds a BA from Cornell University and an MBA from Harvard.
...more
View all episodesView all episodes
Download on the App Store

Biotech 2050 PodcastBy Biotech 2050

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

60 ratings


More shows like Biotech 2050 Podcast

View all
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch by Harry Stebbings

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

530 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,088 Listeners

The Bio Report by Levine Media Group

The Bio Report

40 Listeners

Y Combinator Startup Podcast by Y Combinator

Y Combinator Startup Podcast

228 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

124 Listeners

The Readout Loud by STAT

The Readout Loud

325 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

9,812 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

86 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

33 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

146 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

20 Listeners

The Biotech Startups Podcast by Excedr

The Biotech Startups Podcast

23 Listeners

Beyond Biotech - the podcast from Labiotech by Labiotech

Beyond Biotech - the podcast from Labiotech

3 Listeners

The Top Line by Fierce Life Sciences

The Top Line

15 Listeners

The BioCentury Show by BioCentury

The BioCentury Show

11 Listeners